kabutan

K Pharma, Jan-Mar (1Q) Ordinary Profit Loss Narrows

Thu May 15, 2025 11:30 am JST Earnings

4896 K Pharma,Inc. 【J-GAAP】

Earnings Report

K Pharma,Inc. <4896> [TSE Growth] announced its financial results at noon (11:30) on May 15th. The ordinary loss (non-consolidated) for the first quarter of the fiscal year ending December 2025 (January to March) was a reduced loss of 198 million yen (compared to a loss of 230 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Mar, 2024 0 -230 -230 -233 -20.1 May 13, 2024 J-GAAP
Jan - Mar, 2025 0 -198 -198 -199 -17.2 May 15, 2025 J-GAAP
YoY +13.9% +13.9% +14.6% +14.7%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 0 -423 -422 -426 -36.8 0 Aug 14, 2024 J-GAAP
Jan - Jun, 2025 Guidance -646 -646 -653 -56.3 0 Feb 13, 2025 J-GAAP
YoY -52.7% -53.1% -53.3% -53.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,000 366 344 260 25.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 0 -836 -836 -846 -72.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance -1,368 -1,368 -1,381 -119.0 0 Feb 13, 2025 J-GAAP
YoY -63.6% -63.6% -63.2% -63.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 0 -230 -230 -233 -20.1 -Inf May 13, 2024 J-GAAP
Apr - Jun, 2024 0 -193 -192 -193 -16.7 -Inf Aug 14, 2024 J-GAAP
Jul - Sep, 2024 0 -197 -197 -198 -17.1 -Inf Nov 14, 2024 J-GAAP
Oct - Dec, 2024 0 -216 -217 -222 -19.1 -Inf Feb 13, 2025 J-GAAP
Jan - Mar, 2025 0 -198 -198 -199 -17.2 -Inf May 15, 2025 J-GAAP
YoY +13.9% +13.9% +14.6% +14.7%

Related Articles